APA (7th ed.) Citation

Huang, J., Xu, Y., Chen, Y., Shen, J., Qiu, Y., Li, X., . . . Ma, S. (2024). Revisiting the role of pregnancy zone protein (PZP) as a cancer biomarker in the immunotherapy era. Journal of Translational Medicine, 22(1), 1. https://doi.org/10.1186/s12967-024-05321-5

Chicago Style (17th ed.) Citation

Huang, Jie, Ying Xu, Yidan Chen, Juan Shen, Yao Qiu, Xin Li, Xueqin Chen, and Shenglin Ma. "Revisiting the Role of Pregnancy Zone Protein (PZP) as a Cancer Biomarker in the Immunotherapy Era." Journal of Translational Medicine 22, no. 1 (2024): 1. https://doi.org/10.1186/s12967-024-05321-5.

MLA (9th ed.) Citation

Huang, Jie, et al. "Revisiting the Role of Pregnancy Zone Protein (PZP) as a Cancer Biomarker in the Immunotherapy Era." Journal of Translational Medicine, vol. 22, no. 1, 2024, p. 1, https://doi.org/10.1186/s12967-024-05321-5.